Home › Hemophilia B › New York
Pag-aaral pangklinika para sa Hemophilia B sa New York
5 pag-aaral para sa Hemophilia B ang naghahanap ng mga kalahok sa mga site sa New York.
Opisyal na teksto ng pag-aaral (English)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Cornell University||Joan & Sanford I. Weill Medical College, New York
- Weill Cornell Medical College-New York Presbyterian Hospital, New York
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 2, 2026 · NCT05568719ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Northwell Health HTC, New Hyde Park
Nagre-recruitPhase 3
Edad 1 hanggang 74 · Kalalakihan · Na-update Hul 1, 2026 · NCT05145127An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- American Thrombosis and Hemostasis Network, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT06008938SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Northwell Health, Long Island Jewish, New Hyde Park
Nagre-recruitPhase 4
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT04647227Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.